Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Area of interest

Area of interest

Technology type

Technology type

Topic selection decision

Topic selection decision

Type

Type

Showing 71 to 80 of 360

Guidance in topic selection
TitleTechnology typeDecisionDecision date
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]MedicineAwaiting decision
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (review of TA673) [ID6403]MedicineAwaiting decision
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]MedicineAwaiting decision
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]MedicineNot selected
NVK-002 for treating myopia in people 3 to 17 years [TSID11961]MedicineNot selected
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353MedicineNot selected
Transbronchial lung cryobiopsyProcedureAwaiting decision
Noninvasive Vagus Nerve Stimulation For reactive airway diseaseProcedureFurther information required
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]MedicineNot selected
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]MedicineNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All